Arbovirus Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Arbovirus Testing Market is segmented by Test Type (ELISA-based Tests, RT-PCR based Tests, and Other Test Types), End User (Diagnostic Laboratories, Hospitals, Research Centers, and Other End Users), and Geography.

Market Snapshot

Arbovirus Testing Market_Market Snapshot
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: >5.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The arbovirus testing market is expected to witness a CAGR of around 5.5%, during the forecast period (2020-2025).

  • The major factors accounting for the growth of the arbovirus testing market are the increasing rate of incidence and prevalence of Arbovirus throughout the world, recent advancements in technology, and emerging rapid Serology Tests that may drive the arbovirus testing market during the forecast period.
  •  For example, WHO has reported that the number of dengue cases reported increased over 15-fold over the last two decades, from 505,430 cases in 2000 to over 2,400,138 in 2010 and 3,312,040 in 2015. Deaths from 2000 to 2015 increased from 960 to more than 4032, which strongly supports the increase in the incidence of arboviral diseases. 
  • Thus, the incidence rate of Arboviral diseases drives the growth of the arbovirus testing market during the forecast period. However, the lack of in vitro facilities, lack of awareness, and limited availability of diagnostic testing procedures may restrain the studied market's growth during the forecast period.

Scope of the Report

Arboviruses (Arthropod-borne viruses) are a unique, diverse, and fascinating group of viruses because they cycle between a wide variety of vertebrate hosts and arthropod species. Examples of the arboviral infectious diseases include Dengue, Chikungunya, St. Louis encephalitis, Yellow fever, California encephalitis, Eastern Equine Encephalitis, Powassan, West Nile, and Zika.

By Test Type
ELISA-based Tests
RT-PCR based Tests
Other Test Types
By End User
Diagnostic Laboratories
Hospitals
Research Centers
Other End Users
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

In Test Type Segment, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Tests Dominates the Market and the Same is Expected Over the Forecast Period.

The RT-PCR based tests segment is expected to dominate the arbovirus testing market over the forecast period, attributing to its advantages. A key difference between ELISA (Enzyme-linked immunosorbent assay) and PCR tests is the detection limit. Typically, an ELISA-based method will have a limit of 104-106 CFU/ml, whereas a PCR method can detect in the range of 103 CFU/ml. This difference in detection limit usually means that a longer enrichment time is required for an ELISA method. Even in terms of sensitivity, the PCR technique is very sensitive and specific over ELISA. The wastes produced in the laboratories by adopting the PCR technique are less compared to ELISA. Hence, all these factors together suggest that RT-PCR based tests dominate the arbovirus testing market during the forecast period.

Key Market Trends_Arbovirus Testing Market.png

North America Dominates the Market and the Same is Expected Over the Forecast Period.

North America is expected to dominate the overall market, throughout the forecast period, which has been attributed to the developed economy, increasing health care expenditure, and high adoption of technologically advanced products in the region. Thus, North America dominates the arbovirus testing market during the forecast period. The market in Asia-Pacific is expected to register a high CAGR due to larger population density, which facilitates the easy spread of the arboviral diseases.

Arbovirus Testing Market_Geography

Competitive Landscape

The arbovirus testing market is moderately competitive and consists of several major players. With the increasing consolidations of various organizations and product recalls in the healthcare sector, it is expected to generate competitive rivalry among the key players in the future. Some of the major players of the market are Agilent Technologies Inc., Thermo Fisher Scientific, NovaTec Immundiagnostica GmbH, Euroimmun AG, and Abbott Laboratories, among others.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increase in the Incidence and Prevalence of Arbovirus

      2. 4.2.2 Advancement in Technology

      3. 4.2.3 Rapid Serology Tests

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of In vitro Facilities

      2. 4.3.2 Lack of Awareness and Limited Availability of Diagnostic Testing Procedures

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Test Type

      1. 5.1.1 ELISA-based Tests

      2. 5.1.2 RT-PCR based Tests

      3. 5.1.3 Other Test Types

    2. 5.2 By End User

      1. 5.2.1 Diagnostic Laboratories

      2. 5.2.2 Hospitals

      3. 5.2.3 Research Centers

      4. 5.2.4 Other End Users

    3. 5.3 By Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East & Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies Inc.

      2. 6.1.2 Thermo Fisher Scientific

      3. 6.1.3 NovaTec Immundiagnostica GmbH

      4. 6.1.4 Euroimmun AG

      5. 6.1.5 Abbott Laboratories

      6. 6.1.6 DiaSorin SpA

      7. 6.1.7 Bio-Rad

      8. 6.1.8 Fluke Biomedical

      9. 6.1.9 Copley Scientific

      10. 6.1.10 Distek

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Arbovirus Testing Market market is studied from 2018 - 2026.

The Arbovirus Testing Market is growing at a CAGR of >5.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Agilent Technologies, Inc. , Thermo Fisher Scientific , NovaTec Immundiagnostica GmbH , Euroimmun AG , Abbott Laboratories are the major companies operating in Arbovirus Testing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!